[1. S. Soumyakrishnan, T. Divya, S. Kalayarasan, N. Sriram and G. Sudhandiran, Daidzein exhibits anti-fibrotic effect by reducing the expressions of Proteinase activated receptor 2 and TGFbeta1/ Smad mediated inflammation and apoptosis in Bleomycin-induced experimental pulmonary fibrosis, Biochimie 103 (2014) 23-36; DOI: 10.1016/j.biochi.2014.04.005.10.1016/j.biochi.2014.04.00524769130]Search in Google Scholar
[2. B. Pahari, B. Sengupta, S. Chakraborty, B. Thomas, D. McGowan and P. K. Sengupta, Contrasting binding of fisetin and daidzein in gamma-cyclodextrin nanocavity, J. Photochem. Photobiol. B. 118 (2013) 33-41; DOI: 10.1016/j.jphotobiol.2012.10.010.10.1016/j.jphotobiol.2012.10.010355358923177044]Search in Google Scholar
[3. X. Dong, W. Xu, R. A. Sikes and C. Wu, Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone, Food. Chem. 141 (2013) 1923-1933; DOI: 10.1016/j.foodchem.2013.04.109.10.1016/j.foodchem.2013.04.10923870911]Search in Google Scholar
[4. H. J. Park, Y. K. Jeon, D. H. You and M. J. Nam, Daidzein causes cytochrome c-mediated apoptosis via the Bcl-2 family in human hepatic cancer cells, Food. Chem. Toxicol. 60 (2013) 542-549; DOI: 10.1016/j.fct.2013.08.022.10.1016/j.fct.2013.08.02223959101]Search in Google Scholar
[5. B. S. Pan, Y. Y. Kuo, T. Y. Chen and Y. C. Liu, Anti-oxidative and anti-inflammatory activities of two different species of a Chinese herb I-Tiao-Gung, Life Sci. 77 (2005) 2830-2839; DOI: 10.1016/j. lfs.2005.05.027.]Search in Google Scholar
[6. M. H. Park, J. W. Ju, M. J. Park and J. S. Han, Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice, Eur. J.Pharmacol. 712 (2013) 48-52; DOI: 10.1016/j.ejphar.2013.04.047.10.1016/j.ejphar.2013.04.04723669248]Search in Google Scholar
[7. H. J. Oh, Y. G. Kang, T. Y. Na, H. J. Kim, J. S. Park, W. J. Cho and M. O. Lee, Identification of daidzein as a ligand of retinoic acid receptor that suppresses expression of matrix metalloproteinase-9 in HaCaT cells, Mol. Cell. Endocrin. 376 (2013) 107-113; DOI: 10.1016/j.mce.2013.06.015.10.1016/j.mce.2013.06.01523791815]Search in Google Scholar
[8. Y. Ma, X. Zhao, J. Li and Q. Shen, The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability, Int. J. Nanomed. 7 (2012) 559-570; DOI: 10.2147/IJN.S27641.10.2147/IJN.S27641327743622346351]Search in Google Scholar
[9. T. Loftsson and D. Duchêne, Cyclodextrins and their pharmaceutical applications, Int. J. Pharm. 329 (2007) 1-11; DOI: 10.1016/j.ijpharm.2006.10.044.10.1016/j.ijpharm.2006.10.04417137734]Search in Google Scholar
[10. T. Loftsson and M. E. Brewster, Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization, J. Pharm. Sci. 85 (1996) 1017-1025; DOI: 10.1021/js950534b.10.1021/js950534b8897265]Search in Google Scholar
[11. F. K. Yatsu, L. S. Koester, I. Lula, J. J. Passos and R. Sinisterra, Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction, Carbohyd. Polym. 98 (2013) 726-735; DOI: 10.1016/j.carbpol.2013.06.062.10.1016/j.carbpol.2013.06.06223987405]Search in Google Scholar
[12. F. K. Yatsu, L. S. Koester, I. Lula, J. J. Passos, R. Sinisterra and V. L. Bassani, Cyclodextrin-based pharmaceutics: past, present and future, Nat. Rev. Drug. Discov. 3 (2004) 1023-1035; DOI: 10.1038/ nrd1576.10.1038/nrd157615573101]Search in Google Scholar
[13. S. W. Jun, M. S. Kim, J. S. Kim, H. J. Park, S. Lee, J. S. Woo and S. J. Hwang, Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm. 66 (2007) 413-421; DOI: 10.1016/j. ejpb.2006.11.013.]Search in Google Scholar
[14. Q. L. Zhu, T. Guo, D. N. Xia, X. Y. Li, C. L. Zhu, H. Y. Li, D. F. Ouyang, J. W. Zhang and Y. Gan, Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration, J. Pharm. Pharmacol. 65 (2013) 1107-1117; DOI: 10.1111/jphp.12074.10.1111/jphp.1207423837579]Search in Google Scholar
[15. Q. L. Zhu, X. Y. Li, D. N. Xia, H. Z. Yu, D. Chen, W. W. Fan and Y. Gan, Lipid-based formulations for oral drug delivery: effects on drug absorption and metabolism, Curr. Drug. Metab. 16 (2015) 200-210; DOI: 10.2174/138920021603150812121453.10.2174/13892002160315081212145326279327]Search in Google Scholar
[16. L. M. Ensign, C. Richard and H. Justin, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Adv. Drug Deliv. Rev. 64 (2012) 557-570; DOI: 10.1016/j.addr.2011.12.009. 10.1016/j.addr.2011.12.009332227122212900]Search in Google Scholar